Degree(s)

BSc Chemistry (2009), Balearic Islands University (UIB, Majorca, Spain)
MSc Bioinformatics for Health Sciences (2011), Pompeu Fabra University (UPF, Barcelona, Spain)
PhD Pharmaceutical Sciences (2014), Albert-Ludwigs University (Freiburg, Germany)

Profile

Past Member To and From Dates: August 2015 – July 2018
Past Member Current Position: Research scientist at Roche

Xavier Lucas studied Chemistry at the University of Balearic Islands (Spain). During the last years of his degree, he collaborated at the University’s Computational and Organic Chemistry Department of Prof. Dr. Antonio Frontera and got expertise in ab initio studies of noncovalent interactions. He then moved to Barcelona for his M.Sc. in Bioinformatics, and submitted a M.Sc. thesis which focussed on high-throughput docking approaches for drug design, developed at the group of Prof. Dr. Janusz M. Bujnicki, Poland (“Virtual screening for the discovery of novel inhibitors of NpmA and KamB methyltransferases”, 2011).

Afterwards, he moved to Germany (Pharmaceutical Bioinformatics, University of Freiburg) for his PhD, where he worked on structure-based drug discovery in protein-protein interactions, epigenetics, and cheminformatics (“Discovery of small molecules modulating protein-protein interactions”, 2014).